Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP384856.RAZ4oSEoUhXocK7jpblSTqJ85crptIfd9ogCG2WCXdIB0130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384856.RAZ4oSEoUhXocK7jpblSTqJ85crptIfd9ogCG2WCXdIB0130_provenance.
• NP442173.RAudpLmrjgc2QXFuYn84sf9gI-Dg569CMt4wSsq71OMxU130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442173.RAudpLmrjgc2QXFuYn84sf9gI-Dg569CMt4wSsq71OMxU130_provenance.
• NP382584.RA0OudNwhdluukHBtHoNsSfBkSkLCS0-L2YZvQV3brFHw130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382584.RA0OudNwhdluukHBtHoNsSfBkSkLCS0-L2YZvQV3brFHw130_provenance.
• NP616101.RA03Lx7tWrLP4DMzscPFPsK7wfDvFIk80HQ0Q_qfy7cd4130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616101.RA03Lx7tWrLP4DMzscPFPsK7wfDvFIk80HQ0Q_qfy7cd4130_provenance.
• NP691321.RAcGpP-PfdvRrNO1osXwAj530C4tTjFuu5tIlQIRhQ4JM130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691321.RAcGpP-PfdvRrNO1osXwAj530C4tTjFuu5tIlQIRhQ4JM130_provenance.
• NP712896.RAfM0X-4Qhs6yhVcOFea9qCpLvUzT94qPKdk2tB8WUdw4130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712896.RAfM0X-4Qhs6yhVcOFea9qCpLvUzT94qPKdk2tB8WUdw4130_provenance.
• NP712923.RArOBhzTLKRlWWDxUXSYmQq6ds46YYba6UKE9mXa3Ew1E130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712923.RArOBhzTLKRlWWDxUXSYmQq6ds46YYba6UKE9mXa3Ew1E130_provenance.
• NP847432.RAhuz3byshw8fY4PcC6QkONZ7EXzXjoNH3c4aOaRdHGn0130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847432.RAhuz3byshw8fY4PcC6QkONZ7EXzXjoNH3c4aOaRdHGn0130_provenance.
• NP847508.RAsawzZsr6UHnsqSJT8kcyft5c6mfaxO0156oXSarF7M0130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847508.RAsawzZsr6UHnsqSJT8kcyft5c6mfaxO0156oXSarF7M0130_provenance.
• NP691369.RAKR1B4YDnACuHb0d6ICbDa-2AcboMvhwqQk8MQEdnBMg130_assertion description "[In silico splicing factor binding analysis predicted SRSF1 to bind predominantly to the cancer associated exon 4B, hence, it was hypothesized that SRPK1 activates SRSF1 through phosphorylation, followed by SRSF1 binding to exon 4B and regulation of SLC39A14 splicing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691369.RAKR1B4YDnACuHb0d6ICbDa-2AcboMvhwqQk8MQEdnBMg130_provenance.